<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Padma 28 for intermittent claudication - Stewart, M - 2016 | Cochrane Library</title> <meta content="Padma 28 for intermittent claudication - Stewart, M - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007371.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Padma 28 for intermittent claudication - Stewart, M - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007371.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007371.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Padma 28 for intermittent claudication" name="citation_title"/> <meta content="Marlene Stewart" name="citation_author"/> <meta content="University of Edinburgh" name="citation_author_institution"/> <meta content="Marlene.Stewart@ed.ac.uk" name="citation_author_email"/> <meta content="Joanne R Morling" name="citation_author"/> <meta content="University of Nottingham" name="citation_author_institution"/> <meta content="Heather Maxwell" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD007371.pub3" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/03/29" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007371.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007371.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007371.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Walking; Intermittent Claudication [*drug therapy]; Placebo Effect; Plant Extracts [adverse effects, *therapeutic use]; Randomized Controlled Trials as Topic; Time Factors" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007371.pub3&amp;doi=10.1002/14651858.CD007371.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="na56WA6j";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007371\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007371\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007371\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007371\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ja","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007371.pub3",title:"Padma 28 for intermittent claudication",firstPublishedDate:"Mar 29, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Vascular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=na56WA6j&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007371.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007371.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007371.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007371.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007371.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007371.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007371.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007371.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007371.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007371.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1157 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007371.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full#CD007371-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full#CD007371-sec-0073"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full#CD007371-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full#CD007371-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full#CD007371-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full#CD007371-sec-0022"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full#CD007371-sec-0046"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full#CD007371-sec-0067"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/appendices#CD007371-sec-0078"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/table_n/CD007371StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/table_n/CD007371StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Padma 28 for intermittent claudication</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/information#CD007371-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Marlene Stewart</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/information#CD007371-cr-0003">Joanne R Morling</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007371.pub3/information#CD007371-cr-0004">Heather Maxwell</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/information/en#CD007371-sec-0084">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 29 March 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007371.pub3">https://doi.org/10.1002/14651858.CD007371.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007371-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007371-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007371-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007371-abs-0009">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007371-abs-0001" lang="en"> <section id="CD007371-sec-0001"> <h3 class="title" id="CD007371-sec-0001">Background</h3> <p>Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease that develops in a limb during exercise and is relieved with rest. Most drug treatments of IC have a limited effect in improving walking distance. Padma 28, a Tibetan herbal preparation, has been used to treat IC, but there is debate as to whether Padma 28 produces a clinical benefit beyond the placebo effect. This is an update of a review first published in 2013. </p> </section> <section id="CD007371-sec-0002"> <h3 class="title" id="CD007371-sec-0002">Objectives</h3> <p>To determine whether Padma 28 is effective, compared with placebo or other medications, in increasing pain‐free and maximum walking distance for patients with intermittent claudication. </p> </section> <section id="CD007371-sec-0003"> <h3 class="title" id="CD007371-sec-0003">Search methods</h3> <p>For this update the Cochrane Vascular Trials Search Co‐ordinator searched the Specialised Register (September 2015), the Cochrane Register of Studies ((CENTRAL) (2015, Issue 8)) and clinical trials databases. </p> </section> <section id="CD007371-sec-0004"> <h3 class="title" id="CD007371-sec-0004">Selection criteria</h3> <p>Randomised controlled trials of Padma 28 compared with placebo or other pharmacological treatments in people suffering from IC. </p> </section> <section id="CD007371-sec-0005"> <h3 class="title" id="CD007371-sec-0005">Data collection and analysis</h3> <p>All review authors independently assessed the selected studies and extracted the data. Risk of bias was evaluated independently by two review authors. Depending on the data provided in the individual trials, we extracted mean or median walking distance at the end of the trial, or change in walking distance over the course of the trial, or both. Where not provided, and whenever possible, the statistical significance of differences in these parameters between treatment and placebo groups in individual trials was calculated. Where possible, data were combined by meta‐analysis. </p> </section> <section id="CD007371-sec-0006"> <h3 class="title" id="CD007371-sec-0006">Main results</h3> <p>No new trials were identified in the search for this review update. In total five trials involving 365 participants were included in this review. All trials compared Padma 28 with placebo for at least 16 weeks of follow‐up. Pain‐free and maximum walking distances both increased significantly in the groups treated with Padma 28, with no significant change in the placebo group. In general, the studies presented results comparing the treatment arms before and after treatment but made no comparisons between the Padma 28 and placebo groups. Pooled data of maximum walking distance after treatment with Padma 28 and placebo from two studies (193 participants) indicated a higher maximum walking distance (mean difference (MD) 95.97 m, 95% confidence interval (CI) 79.07 m to 112.88 m, P &lt; 0.00001, very low quality evidence) in the Padma 28 group compared with placebo. The clinical importance of these observed changes in walking distance is unclear as no quality of life data were reported. There was no effect on ankle brachial index (ABI): change in ABI values between baseline and six months follow up MD ‐0.01, 95% CI ‐0.07 to 0.05, 1 study, 56 participants, P = 0.72, very low quality evidence). Mild side effects, especially gastrointestinal discomfort, tiredness and skin eruption, were reported but this outcome was not different between the Padma 28 and placebo groups (odds ratio 1.09, 95% CI 0.42 to 2.83, four studies, 231 participants, P = 0.86, very low quality evidence). </p> </section> <section id="CD007371-sec-0007"> <h3 class="title" id="CD007371-sec-0007">Authors' conclusions</h3> <p>Some evidence exists from individual trials to suggest that Padma 28 may be effective in increasing walking distances, at least in the short term (four months), in people with IC. Side effects do not appear to be a problem. However, the longer term effects of treatment are unknown and the clinical significance of the improvements in walking distance are questionable. Moreover, the quality of the evidence is limited by the small sample size of the available trials, limited reporting of statistical analyses that compared treatment groups, and relatively high withdrawal rates that were linked to the outcome. That is, patients were withdrawn if they failed to improve walking distance. There was also evidence of publication bias. We therefore feel there is currently insufficient evidence to draw conclusions regards the effectiveness of Padma 28 in the routine management of IC. Further well‐designed research would be required to determine the true effects of this herbal preparation. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007371-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007371-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD007371-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD007371-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007371-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD007371-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD007371-abs-0005">日本語</a> </li> <li class="section-language"> <a class="" href="full/ru#CD007371-abs-0004">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007371-abs-0002" lang="en"> <h3>Padma 28 for intermittent claudication</h3> <p>Background</p> <p>Intermittent claudication (IC) is pain in the leg that occurs on exercise and is relieved by rest. It is caused by an inadequate blood supply to the legs due to blockage of arteries. Conservative drug treatment is commonly used in an attempt to improve walking distance in these patients. Padma 28 is a Tibetan herbal preparation used for treating intermittent claudication. </p> <p>Study characteristics and key results</p> <p>This review on the effects of Padma 28 includes five trials with a total of 365 participants (current until September 2015). The review showed that Padma 28 has some beneficial effects in improving maximum and pain‐free walking distance. The groups treated with placebo did not show an improved maximum and pain‐free walking distance. Unfortunately the studies reported insufficient data to allow the comparison of the change in walking distances in the Padma 28 group with the change in walking distances in the placebo group. Combining the data of maximum walking distance after treatment in two studies showed that there was a longer maximum walking distance in the Padma 28 group compared with the placebo group after 16 weeks of treatment. No change in ankle brachial pressure was observed. Mild side effects such as gastrointestinal discomfort, tiredness and skin eruption were also noted but these were not different between the Padma 28 and placebo groups. </p> <p>Quality of the evidence</p> <p>Overall, the quality of the studies was low, with evidence of publication bias, small number of trials, limited reporting of the analyses that compared treatment groups and bias due to a high percentage of withdrawals in the placebo groups because of lack of improvement or deterioration of the overall condition. We therefore feel there is currently insufficient evidence to draw conclusions about the effectiveness of Padma 28 in the routine management of IC. Further well‐designed research would be required to determine the true effects of this herbal preparation. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007371-sec-0073" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007371-sec-0073"></div> <h3 class="title" id="CD007371-sec-0074">Implications for practice</h3> <section id="CD007371-sec-0074"> <p>Some evidence exists from individual trials to suggest that patients with intermittent claudication (IC) may benefit from daily Padma 28 in terms of moderate, short term (four month) improvements in walking distances. Side effects do not appear to be a problem. However, the longer term effects of treatment are unknown and the clinical significance of the improvements in walking distance are questionable. Moreover, the quality of the evidence is very low, limited by the small sample size and difference in baseline characteristics such as smoking of the available trials, lack of detail on key elements required to assess other sources of bias for example around randomisation and blinding, limited reporting of statistical analyses used to compare treatment groups, and relatively high withdrawal rates that were linked to outcome, that is withdrawn if failed to improve walking distance. There was also evidence of publication bias. We therefore feel there is currently insufficient evidence to draw conclusions regards the effectiveness of Padma 28 in the routine management of intermittent claudication. </p> </section> <h3 class="title" id="CD007371-sec-0075">Implications for research</h3> <section id="CD007371-sec-0075"> <p>Further research into Padma 28 as a treatment for IC would be beneficial in order to formulate a definitive answer. Large methodologically sound trials need to be conducted. The main outcomes of walking distance, ABI, and quality of life are needed for adequate evaluation in order to identify clinically relevant changes. Further trials in which patients are followed up over a long term period are also needed. In addition, any future studies should ensure the outcomes reported include the assessment of change between the treatment groups studied. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD007371-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD007371-sec-0015"></div> <div class="table" id="CD007371-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Padma 28 versus placebo</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Should Padma 28 versus placebo be used for intermittent claudication?</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with symptomatic intermittent claudication<br/> <b>Setting:</b> outpatient setting<br/> <b>Intervention:</b> Padma 28<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Padma 28</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain free walking distance (PFWD)<br/> follow up: 4 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>see comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unable to pool data, one of the two studies did not provide variability data. Review authors deemed the limited available data inappropriate for imputation </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in maximum walking distance (MWD)<br/> follow up: 4 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in maximum walking distance was</p> <p> ‐ 1.4 metres</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in maximum walking distance in the Padma 28 group was 77.1 metres more (53.41 more to 100.79 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Final value MWD<br/> assessed with: treadmill<br/> follow up: 4 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean final value maximum walking distance was 77.05 metres</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean final value maximum walking distance in the Padma 28 group was 95.97 metres more (79.07 more to 112.88 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>193<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Adverse effects<br/> follow up: 4 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>OR 1.09<br/> (0.42 to 2.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>231<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 5 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>99 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>107 per 1000<br/> (44 to 237) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>52 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>56 per 1000<br/> (22 to 134) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Final value ankle brachial index (ABI)<br/> follow up: 4 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean final value ankle brachial index was 0.73</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean final value ankle brachial index in the Padma 28 group was 0.01 fewer (0.11 fewer to 0.09 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in ABI<br/> follow up: 4 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in ankle brachial index was ‐ 0.01</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in ankle brachial index in the Padma 28 group was 0.01 fewer (0.07 fewer to 0.05 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>ABI:</b> Ankle brachial index; <b>CI:</b> Confidence interval; <b>MWD:</b> Maximum walking distance; <b>RCT:</b> Randomised controlled trial <b>OR:</b> Odds ratio; <b>WD:</b> Walking distance </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> possible publication bias as data of one study unavailable ‐ downgraded by one level<br/> <sup>2</sup> one single study, unable to asses inconsistency ‐ downgraded by one level<br/> <sup>3</sup> high withdrawal rate linked to the outcome that is they were withdrawn because of failing to improve WD or as a result of deterioration in overall condition in <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> ‐ downgraded by one level<br/> <sup>4</sup> limited reporting of statistical analyses that compared the PADMA 28 and placebo groups: WD after treatment used rather than change in WD. Since the baseline WDs varied between the studies the use of WDs after treatment could have introduced bias ‐ downgraded by one level<br/> <sup>5</sup> differences between studies in baseline characteristics such as smoking: e.g. baseline smoking rates 90% in <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> but 50% in <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> and <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> ‐ downgraded by one level<br/> <sup>6</sup> high withdrawal rate linked to the outcome that is they were withdrawn because of failing to improve WD or as a result of deterioration in overall condition in <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> ‐ downgraded by one level<br/> <sup>7</sup> high withdrawal rate linked to the outcome that is they were withdrawn because of failing to improve WD or as a result of deterioration in overall condition in <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> ‐ downgraded by one level </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007371-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007371-sec-0016"></div> <section id="CD007371-sec-0017"> <h3 class="title" id="CD007371-sec-0017">Description of the condition</h3> <p>Peripheral arterial occlusive disease is a leading cause of morbidity in older people. The prevalence of intermittent claudication varies by age and sex. A review of nine studies found age standardised prevalence rates to be consistently higher amongst men than women (men 0.8% to 2.9% versus women 0.6% to 1.6%) (<a href="./references#CD007371-bbs2-0024" title="MeijerWT , HoesAW , RutgersD , BotsML , HofmanA , GrobbeeDE . Peripheral arterial disease in the elderly: The Rotterdam study. Arteriosclerosis, Thrombosis and Vascular Biology1998;18:185‐92. ">Meijer 1998</a>). In addition, there was a clear increase in prevalence with age, rising from 1.0% in men aged 55 to 59 years to 6.0% in men aged 85 years and older (0.7% and 2.5% respectively for women). </p> <p>Intermittent claudication (IC) presents as the occurrence of pain, ache, cramps, or a sense of fatigue due to inadequate blood supply to locomotor muscles distal to occlusive lesions of the supplying arteries. The pain tends to start after a person has walked a certain distance. The progression of symptoms soon compels the person to stop (<a href="./references#CD007371-bbs2-0028" title="RoseGA . The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bulletin of the World Health Organization1962;27:645‐58. ">Rose 1962</a>). Intermittent claudication per se rarely represents a life‐threatening condition. However, it is associated with reduced survival due to generalised arteriosclerosis resulting in high frequencies of heart disease and stroke (<a href="./references#CD007371-bbs2-0008" title="BalkauB , VrayM , EschwegeE . Epidemiology of peripheral arterial disease. Journal of Cardiovascular Pharmacology1994;23 Suppl 3:S8‐16. ">Balkau 1994</a>; <a href="./references#CD007371-bbs2-0012" title="CassarK . Intermittent claudication. British Medical Journal2006;333(7576):1002‐5. ">Cassar 2006</a>; <a href="./references#CD007371-bbs2-0021" title="KannelWB , SkinnerJJ , Jr , SchwartzMJ , ShurtleffD . Intermittent claudication. Incidence in the Framingham Study. Circulation1970;41(5):875‐83. ">Kannel 1970</a>). Treatment for improving IC is usually conservative (<a href="./references#CD007371-bbs2-0013" title="CoffmanJD . Intermittent claudication‐‐be conservative. New England Journal of Medicine1991;325(8):577‐8. ">Coffman 1991</a>; <a href="./references#CD007371-bbs2-0027" title="PittlerMH , ErnstE . Complementary therapies for peripheral arterial disease: systematic review. Atherosclerosis2005;181(1):1‐7. ">Pittler 2005</a>) and includes the avoidance or treatment of risk factors such as smoking, diabetes, hypertension, hypercholesterolaemia, and the promotion of physical activity (<a href="./references#CD007371-bbs2-0010" title="BendermacherBLW , WilligendaelEM , TeijinkJAW , PrinsMH . Supervised exercise therapy versus non‐supervised exercise therapy for intermittent claudication. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD005263.pub2] ">Bendermacher 2009</a>; <a href="./references#CD007371-bbs2-0018" title="GardnerAW , PoehlmanET . Exercise rehabilitation programs for the treatment of claudication pain. A meta‐analysis. Journal of the American Medical Association1995;274(12):975‐80. ">Gardner 1995</a>; <a href="./references#CD007371-bbs2-0034" title="WatsonL , EllisB , LengGC . Exercise for intermittent claudication. Cochrane Database of Systematic Reviews2008, Issue 4. [DOI: 10.1002/14651858.CD000990.pub2] ">Watson 2008</a>). Additionally, pharmacologic interventions are available to treat this condition and in some cases surgery may be beneficial (<a href="./references#CD007371-bbs2-0014" title="deBackerTLM , Vander SticheleR , LehertP , VanBortelL . Naftidrofuryl for intermittent claudication. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.CD001368.pub4] ">de Backer 2012</a>; <a href="./references#CD007371-bbs2-0017" title="FowkesG , GillespieIN . Angioplasty (versus non surgical management) for intermittent claudication. Cochrane Database of Systematic Reviews2008, Issue 4. [DOI: 10.1002/14651858.CD000017] ">Fowkes 2008</a>; <a href="./references#CD007371-bbs2-0029" title="SalhiyyahK , SenanayakeE , Abdel‐HadiM , BoothA , MichaelsJA . Pentoxifylline for intermittent claudication. Cochrane Database of Systematic Reviews2012, Issue 1. [DOI: 10.1002/14651858.CD005262.pub2] ">Salhiyyah 2012</a>). </p> </section> <section id="CD007371-sec-0018"> <h3 class="title" id="CD007371-sec-0018">Description of the intervention</h3> <p>There are many types of drugs used for routine risk factor management in peripheral arterial disease (PAD), including antiplatelet agents and lipid‐lowering drugs to prevent cardiovascular events. Additionally, some vasoactive drugs have been used for the treatment of symptoms and to improve walking distances. </p> <p>The use of dietary supplements (especially herbal remedies) has been increasing for the treatment of IC (<a href="./references#CD007371-bbs2-0025" title="MelzerJ , BrignoliR , DiehmC , ReichlingJ , DoDD , SallerR . Treating intermittent claudication with Tibetan medicine Padma 28: does it work?. Artherosclerosis2006;189(1):39‐46. ">Melzer 2006</a>; <a href="./references#CD007371-bbs2-0027" title="PittlerMH , ErnstE . Complementary therapies for peripheral arterial disease: systematic review. Atherosclerosis2005;181(1):1‐7. ">Pittler 2005</a>). This review focuses on the Tibetan herbal preparation Padma 28, based on an ancient Lamaistic formula, which was introduced into Europe by Badmajeff (<a href="./references#CD007371-bbs2-0022" title="KowalewskiK . Vladimir Badmajeff, Tibetan doctor in Europe. Journal for the Research in Indian Medicine, New Delhi1973;8(2):101‐10. ">Kowalewski 1973</a>). The preparation consists of a mixture of 22 different, mainly herbal ingredients, ranging from aconite, calendula, cardamom, camphor, and hydrated calcium sulphate to valerian components (<a href="./references#CD007371-bbs2-0032" title="SmulskiHS , WojcickiJ . Placebo‐controlled double‐blind study to investigate the efficacy of the Tibetan plant preparation Padma 28 in the treatment of intermittent claudication. Forschende Komplementarmedizin1994;1:18‐26. ">Smulski 1994</a>). It has been sold for about 20 years as an over‐the‐counter medicine for the treatment of IC, almost exclusively in Switzerland where it is manufactured (<a href="./references#CD007371-bbs2-0020" title="HurlimannF . Treatment of peripheral bleeding disorders with Padma 28 ‐ 15 years experience [Behandlung peripherer Durchblutungsstorungen mit PADMA 28‐Erfahrungen uber 15 Jahre]. Schweizerische Zeitschrift für Ganzheitsmedizin1992;4 Suppl 1:20‐1. ">Hurlimann 1992</a>). See <a href="./appendices#CD007371-sec-0079">Appendix 1</a> for the full product details. </p> </section> <section id="CD007371-sec-0019"> <h3 class="title" id="CD007371-sec-0019">How the intervention might work</h3> <p>Various mechanisms of the action of Padma 28 have been postulated including lipid‐lowering activity (<a href="./references#CD007371-bbs2-0030" title="SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. ">Samochowiec 1987a</a>; <a href="./references#CD007371-bbs2-0032" title="SmulskiHS , WojcickiJ . Placebo‐controlled double‐blind study to investigate the efficacy of the Tibetan plant preparation Padma 28 in the treatment of intermittent claudication. Forschende Komplementarmedizin1994;1:18‐26. ">Smulski 1994</a>), inhibition of blood lipid oxidisability (<a href="./references#CD007371-bbs2-0011" title="Brunner‐La RoccaHP , SchindlerR , SchlumpfM , SallerM , SuterM . Effects of the Tibetan herbal preparation PADMA 28 on blood lipids and lipid oxidisability in subjects with mild hypercholesterolaemia. Vasa2005;34(1):11‐7. ">Brunner‐La Rocca 2005</a>), an increase in fibrinolytic activity (<a href="./references#CD007371-bbs2-0035" title="WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Winther 1994</a>), inhibition of platelet aggregation (<a href="./references#CD007371-bbs2-0030" title="SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. ">Samochowiec 1987a</a>; <a href="./references#CD007371-bbs2-0032" title="SmulskiHS , WojcickiJ . Placebo‐controlled double‐blind study to investigate the efficacy of the Tibetan plant preparation Padma 28 in the treatment of intermittent claudication. Forschende Komplementarmedizin1994;1:18‐26. ">Smulski 1994</a>), modulation of neutrophil derived free radicals (<a href="./references#CD007371-bbs2-0023" title="MatznerY , SallonS . The effect of Padma 28, a traditional herbal preparation on human neutrophil function. Journal of Clinical and Laboratory Immunology1995;46(1):13‐23. ">Matzner 1995</a>), inhibition of lysozyme release from neutrophils (<a href="./references#CD007371-bbs2-0023" title="MatznerY , SallonS . The effect of Padma 28, a traditional herbal preparation on human neutrophil function. Journal of Clinical and Laboratory Immunology1995;46(1):13‐23. ">Matzner 1995</a>), a decrease in the oxidative burst response of monocytes (<a href="./references#CD007371-bbs2-0035" title="WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Winther 1994</a>), inhibition of cellular response to growth factors involved in atherosclerosis and restenosis (<a href="./references#CD007371-bbs2-0026" title="NavabR , AingornH , FallavollitaL , SallonS , MechoulamR , GinsburgI , et al. PADMA‐28, a traditional Tibetan herbal preparation, blocks cellular responses to bFGF and IGF‐I. Inflammopharmacology2004;12(4):373‐89. ">Navab 2004</a>), and inhibition of inflammatory cytokine production (<a href="./references#CD007371-bbs2-0009" title="BarakV , KalickmanI , HalperinT , BirkenfeldS , GinsburgI . PADMA‐28, a Tibetan herbal preparation is an inhibitor of inflammatory cytokine production. European Cytokine Network2004;15(3):203‐9. ">Barak 2004</a>) and anti‐inflammatory mechanisms in the vessel wall (<a href="./references#CD007371-bbs2-0015" title="ExnerM , RaithM , HolzerG , GmeinerB , WagnerO , KapiotisS . Anti‐inflammatory mechanisms of the Tibetan herbal preparation Padma28 in the vessel wall. Forschende Komplementärmedizin2006;13 Suppl 1:13‐7. ">Exner 2006</a>). </p> </section> <section id="CD007371-sec-0020"> <h3 class="title" id="CD007371-sec-0020">Why it is important to do this review</h3> <p>There has been considerable debate on whether Padma 28 produces a clinical benefit beyond the placebo effect. Additionally, the lack of standardisation and the uncertain bioavailability of the mixture have been criticised. Therefore, a review assessing the evidence on the efficacy of Padma 28 for the treatment of IC is warranted. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007371-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007371-sec-0021"></div> <p>To determine whether Padma 28 is effective, compared with placebo or other medications, in increasing pain‐free and maximum walking distance for patients with intermittent claudication (IC). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007371-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007371-sec-0022"></div> <section id="CD007371-sec-0023"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007371-sec-0024"> <h4 class="title">Types of studies</h4> <p>We considered all randomised controlled trials of Padma 28 compared with placebo or other pharmacological treatments. </p> </section> <section id="CD007371-sec-0025"> <h4 class="title">Types of participants</h4> <p>We included participants with symptomatic IC (Fontaine stage II) (<a href="./references#CD007371-bbs2-0016" title="FontaineR , KimM , KienyR . Surgical treatment for peripheral vascular disease [Die chirurgische Behandlung der peripherern Durchblutungsstorungen]. Helvetica Chirurgica Acta1954;5/6:499‐533. ">Fontaine 1954</a>) due to atherosclerotic disease, diagnosed either clinically or by questionnaire, and considered suitable for conservative treatment. </p> <p>We excluded studies of participants diagnosed as having lower limb atherosclerosis by clinical examination or questionnaire but who were asymptomatic, that is who did not show symptoms. </p> </section> <section id="CD007371-sec-0026"> <h4 class="title">Types of interventions</h4> <p>We included all types of Padma 28 regimens versus placebo or other pharmacological treatments. </p> </section> <section id="CD007371-sec-0027"> <h4 class="title">Types of outcome measures</h4> <section id="CD007371-sec-0028"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD007371-list-0001"> <li> <p>Pain‐free walking distance (PFWD) or the initial claudication distance (ICD), which is the distance walked on a treadmill before the onset of pain. </p> </li> <li> <p>Maximum walking distance (MWD) or total walking distance (TWD) or the absolute claudication distance (ACD), which is the maximum or absolute distance walked on a treadmill. </p> </li> </ol> </p> </section> <section id="CD007371-sec-0029"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD007371-list-0002"> <li> <p>Proportion of patients experiencing adverse events.</p> </li> <li> <p>Ankle brachial index (ABI), calculated by dividing the systolic blood pressure in the ankle by that in the arm. </p> </li> </ol> </p> </section> </section> </section> <section id="CD007371-sec-0030"> <h3 class="title">Search methods for identification of studies</h3> <p>There was no restriction on language or publication status.</p> <section id="CD007371-sec-0031"> <h4 class="title">Electronic searches</h4> <p>For this update the Cochrane Vascular Trials Search Co‐ordinator (TSC) searched the Specialised Register (September 2015). In addition the TSC searched the Cochrane Register of Studies (CRS) <a href="http://www.metaxis.com/CRSWeb/Index.asp" target="_blank">http://www.metaxis.com/CRSWeb/Index.asp</a> ((CENTRAL) (2015, Issue 8)). See <a href="./appendices#CD007371-sec-0080">Appendix 2</a> for details of the search strategy used to search the CRS. The Specialised Register is maintained by the TSC and is constructed from weekly electronic searches of MEDLINE, EMBASE, CINAHL, AMED, and through handsearching relevant journals. The full list of the databases, journals and conference proceedings which have been searched, as well as the search strategies used are described in the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PVD/frame.html" target="_blank">Specialised Register</a> section of the Cochrane Vascular module in the<i>Cochrane Library</i> (<a href="http://www.cochranelibrary.com/" target="_blank">www.cochranelibrary.com</a>). </p> <p>The following trial databases were searched by the TSC for details of ongoing and unpublished studies (September 2015) using the term Padma: </p> <p> <ul id="CD007371-list-0003"> <li> <p>World Health Organization International Clinical Trials Registry (<a href="http://apps.who.int/trialsearch/" target="_blank">http://apps.who.int/trialsearch/</a>); </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">http://clinicaltrials.gov/</a>); </p> </li> <li> <p>ISRCTN registry (<a href="http://www.controlled-trials.com/" target="_blank">http://www.controlled‐trials.com/</a>) </p> </li> <li> <p>Nederlands Trials Register (<a href="http://www.trialregister.nl/trialreg/admin/rctsearch.asp" target="_blank">http://www.trialregister.nl/trialreg/admin/rctsearch.asp</a>). </p> </li> </ul> </p> </section> <section id="CD007371-sec-0032"> <h4 class="title">Searching other resources</h4> <p>For the original review version published in 2013 we contacted one pharmaceutical company producing Padma 28 (Padma AG, Swizerland) for information on both unpublished and ongoing trials. The company was unwilling to release data for this review and referred to a prior meta‐analysis using unpublished data by <a href="./references#CD007371-bbs2-0025" title="MelzerJ , BrignoliR , DiehmC , ReichlingJ , DoDD , SallerR . Treating intermittent claudication with Tibetan medicine Padma 28: does it work?. Artherosclerosis2006;189(1):39‐46. ">Melzer 2006</a>. We were unable to obtain any additional data from the authors of this meta‐analysis. </p> </section> </section> <section id="CD007371-sec-0033"> <h3 class="title" id="CD007371-sec-0033">Data collection and analysis</h3> <section id="CD007371-sec-0034"> <h4 class="title">Selection of studies</h4> <p>All review authors (JM, HM, MS) independently examined the studies identified by the search strategy for eligibility for inclusion in the review. </p> </section> <section id="CD007371-sec-0035"> <h4 class="title">Data extraction and management</h4> <p>All review authors (JM, HM, MS) independently extracted data using a standard data extraction form designed by Cochrane Vascular. The information extracted included: study design, method of allocation and concealment, degree of blinding, power calculation, exclusion post‐randomisation, number of withdrawals and reasons, country where the study was undertaken, setting, participant numbers, age and sex, inclusion and exclusion criteria, interventions, duration of the study, and primary and secondary outcomes as defined in <a href="#CD007371-sec-0027">Types of outcome measures</a>. </p> <p>Disagreements were resolved by discussion.</p> </section> <section id="CD007371-sec-0036"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (JM, MS) independently assessed the sources of systematic bias of the included studies according to the guidelines in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007371-bbs2-0019" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Intervensions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. ">Higgins 2011</a>). Any disagreements were resolved by discussion. </p> <p>We examined five key domains as part of the Cochrane 'Risk of bias' tool: selection bias, performance bias. attrition bias, detection bias, and reporting bias. We assessed and classified these domains as either a low risk of bias or a high risk of bias. Where insufficient detail was reported in a study to assess the risk we reported this as 'unclear'. In addition to the five key domains, we reported any other form of potential bias noted in the study. </p> </section> <section id="CD007371-sec-0037"> <h4 class="title">Measures of treatment effect</h4> <p>We performed statistical analyses according to the statistical guidelines for review authors by Cochrane Vascular. We analysed the data using the Review Manager 5 software distributed by Cochrane. </p> <p>We summarised the continuous primary outcome measures PFWD and MWD using metres as the main unit for walking distance. If only time to onset of claudication symptoms or walking cessation was provided, we converted it to walking distance in metres by multiplying the speed of the treadmill (metres per second) by the walking time (seconds). We reported both final walking distance data and change in walking distance data between baseline and follow‐up where available. </p> <p>For the continuous data, we extracted the mean and standard deviation (SD) values where available. Investigation determined that two of the studies that stated that their results were median values were in fact reporting mean values (<a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a>; <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a>). Where standard errors (SE) were reported (<a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a>), we calculated the SD using the agreed formula SD = SE x √N (<a href="./references#CD007371-bbs2-0019" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Intervensions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. ">Higgins 2011</a>). </p> <p>For the dichotomous secondary outcome relating to experiencing adverse effects we reported the odds ratio (OR) and 95% confidence interval (CI). The secondary outcome ABI was measured as a continuous variable. We reported both final values and change in ABI data between baseline and follow‐up where available. </p> </section> <section id="CD007371-sec-0038"> <h4 class="title">Unit of analysis issues</h4> <p>The individual participant was the unit of analysis.</p> </section> <section id="CD007371-sec-0039"> <h4 class="title">Dealing with missing data</h4> <p>Where data were missing we attempted to contact the original investigator and requested the missing data, however these were not available. </p> <p>Where outcome variables were not reported we analysed the available data. For missing data related to loss to follow‐up we assumed the data to be missing at random. </p> <p>Since the validity of the study would be affected by whether the characteristics of those participants with missing data were reported and whether any bias was likely to have occurred, we presented information on missing data for each study in the <a href="./references#CD007371-sec-0090" title="">Characteristics of included studies</a> table. We considered the potential impact of missing data when making the final conclusions. </p> <p>In studies where medians and interquartile ranges (IQRs) were presented and and any skewing was deemed minor from the presented outcome data, the median was assumed to be the mean and the SD was imputed according to chapter 7.7.3.5 of the Cochrane <i>Handbook for Systematic Reviews for Interventions</i> (<a href="./references#CD007371-bbs2-0019" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Intervensions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. ">Higgins 2011</a>). </p> </section> <section id="CD007371-sec-0040"> <h4 class="title">Assessment of heterogeneity</h4> <p>We explored clinical heterogeneity in the studies using the previously identified characteristics of the studies and the quality of the included studies. We used the Chi<sup>2</sup> test to test for heterogeneity where data were pooled. A P value of &lt; 0.10 was deemed to indicate heterogeneity. </p> </section> <section id="CD007371-sec-0041"> <h4 class="title">Assessment of reporting biases</h4> <p>Reporting biases commonly arise when the nature and direction of research findings are unexpected. When contacting the pharmaceutical company, we obtained a meta‐analysis for Padma 28 (<a href="./references#CD007371-bbs2-0025" title="MelzerJ , BrignoliR , DiehmC , ReichlingJ , DoDD , SallerR . Treating intermittent claudication with Tibetan medicine Padma 28: does it work?. Artherosclerosis2006;189(1):39‐46. ">Melzer 2006</a>) and one unpublished trial was detected in this meta‐analysis. The results of most trials in this meta‐analysis showed a positive effect on walking distance whereas, according to <a href="./references#CD007371-bbs2-0025" title="MelzerJ , BrignoliR , DiehmC , ReichlingJ , DoDD , SallerR . Treating intermittent claudication with Tibetan medicine Padma 28: does it work?. Artherosclerosis2006;189(1):39‐46. ">Melzer 2006</a>'s description, the unpublished study showed a non‐significant difference between treatments. We did not draw funnel plots according to the guidelines in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007371-bbs2-0019" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Intervensions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. ">Higgins 2011</a>) because there were not enough trials included in the review to give a meaningful result. </p> </section> <section id="CD007371-sec-0042"> <h4 class="title">Data synthesis</h4> <p>Where meta‐analyses were possible, data were pooled using a fixed‐effect model. Where it was not possible to pool the data, we reported the data as presented by the studies. </p> </section> <section id="CD007371-sec-0043"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We did not plan to perform subgroup analysis in this review.</p> </section> <section id="CD007371-sec-0044"> <h4 class="title">Sensitivity analysis</h4> <p>Sensitivity analyses were performed, where possible, using imputed or converted median final values of walking distance and ABI. If in future updates sufficient studies are included, we will perform a sensitivity analysis to assess the impact of methodological quality of the studies by excluding studies with low methodological quality. </p> <section id="CD007371-sec-0045"> <h5 class="title">Summary of findings</h5> <p>We created a 'Summary of findings' table according to <a href="./references#CD007371-bbs2-0019" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Intervensions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. ">Higgins 2011</a> and GRADE (<a href="./references#CD007371-bbs2-0007" title="AtkinsD , BestD , BrissPA , EcclesM , Falck‐YtterY , FlottorpS , et al. Grading quality of evidence and strength of recommendations. British Medical Journal2004;328(7454):1490‐4. ">Atkins 2004</a>). We used the GRADEpro (GRADEproGDT) software (<a href="http://www.guidelinedevelopment.org/" target="_blank">http://www.guidelinedevelopment.org/</a>) to assist in the preparation of the 'Summary of findings' table. </p> <p>We reported the following outcomes in the 'Summary of findings' table:</p> <p> <ul id="CD007371-list-0004"> <li> <p>PFWD</p> </li> <li> <p>MWD</p> </li> <li> <p>adverse events</p> </li> <li> <p>ABI</p> </li> </ul> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007371-sec-0046" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007371-sec-0046"></div> <section id="CD007371-sec-0047"> <h3 class="title">Description of studies</h3> <section id="CD007371-sec-0048"> <h4 class="title">Results of the search</h4> <p>See <a href="#CD007371-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD007371-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD007371-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>No new studies were identified in the search for this review update. The methods described above therefore reflect the work carried out for the original version of this review published in 2013, except for the creation of the 'Summary of findings' table which was newly added to this version of the review. </p> </section> <section id="CD007371-sec-0049"> <h4 class="title">Included studies</h4> <section id="CD007371-sec-0050"> <h5 class="title">Type of studies</h5> <p>There were 12 reports to five studies included in this review (<a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a>; <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a>; <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a>; <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a>; <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a>). All were reported as randomised controlled, double‐blinded studies. The trials were carried out in hospitals in Denmark, Germany, Poland, and Israel. </p> </section> <section id="CD007371-sec-0051"> <h5 class="title">Type of participants</h5> <p>For the five studies a total of 331 participants were included. Three hundred and sixty‐five participants were randomised in the studies with 34 subsequently withdrawing or being lost to follow‐up. Data were not available to allow last observation carried forward (LOCF) analysis to be carried out. The numbers in each study were as follows (number completing study/number commencing study): <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> 36/40; <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> 59/72; <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> 100/100; <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> 43/53; and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> 93/100. The trials were published between 1985 and 1998. </p> <p>Diagnosis of IC was confirmed in all participants by interview for a typical IC history and objective clinical examination. Clinical examination methods varied between the studies, including: ABI (<a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a>), objective criteria for peripheral arterial occlusive disease Fontaine stage II (<a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a>; <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a>), or conventional angiography and Doppler ultrasound (<a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a>; <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a>). </p> <p>The distribution of participants' age (mean or median values 54 to 73 years) and sex (men 53% to 77%) were broadly similar in the five studies. Whether the participants were smokers was indicated in four trials (<a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a>; <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a>; <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a>; <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a>) with varied proportions: approximately 50% in <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> and <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> and approximately 90% in <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a>. Co‐morbidities, surgical history, medication history, and location of peripheral arterial obstruction were similar amongst all five studies. </p> <p>The baseline maximum walking distance (MWD) differed between studies (150 m to 300 m) although the pain‐free walking distances (PFWD) were comparable. Otherwise, the conditions for inclusion and exclusion were similar. </p> </section> <section id="CD007371-sec-0052"> <h5 class="title">Type of interventions</h5> <p>All five trials compared Padma 28 with a placebo. There was no comparison of Padma 28 with other medications. The dose of Padma 28 provided to the treatment groups in the trials varied between 340 mg and 403 mg per capsule with a total daily dose of between 1360 mg and 2280 mg. All of the studies had a treatment period of 16 weeks or four months with the exception of <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> which lasted six months. </p> </section> <section id="CD007371-sec-0053"> <h5 class="title">Outcomes</h5> <p>MWD was measured in four trials during a four‐month or 16‐week period of treatment with follow‐up assessments every four weeks (<a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a>; <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a>; <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a>; <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a>). Of these four studies, two also investigated PFWD (<a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a>; <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a>). For the walking test, the studies used a treadmill with a standard intensity (3 km/hour at 13 º as slope) with the exception of one study (<a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a>), which used a variable condition (2.5 to 4 km/hour and 8 º to 16 º slope). </p> <p>All five studies reported on the adverse effects of treatment with Padma 28. <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> and <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> found no adverse effects. <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> did not report numbers of adverse effects or numbers of participants affected by adverse effects. However, <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> did report that all side effects were mild in nature, that none required special treatment, and that no participants stopped because of adverse effects. In addition, <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> stated that there was no significant difference between the treatment groups in reported adverse effects. The number of participants experiencing an adverse effect was reported in <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> (numbers of each adverse effect) and <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> (total number of any adverse events). Only <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> compared the prevalence of adverse effects between the treatment and placebo group. </p> <p>ABI was investigated by Mehlsen and Sallon (<a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a>; <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a>). The ABI was obtained at baseline and the end of treatment in both trials and not during follow‐up. <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> measured blood pressure in the upper arm and ankle at rest and after exercise, both before and after treatment. However, the blood pressure measures were reported as differences in blood pressure at rest and after exercise. Therefore, ABI values could not be extracted. </p> <p>For full details of the included studies see <a href="./references#CD007371-sec-0090" title="">Characteristics of included studies</a>. </p> </section> </section> <section id="CD007371-sec-0054"> <h4 class="title">Excluded studies</h4> <p>One trial was excluded from this review. This trial explored the efficacy of Padma 28 for peripheral arterial occlusive disease and was a controlled clinical trial but was not randomised (<a href="./references#CD007371-bbs2-0006" title="HurlimannF . [A lamaistic formula for the treatment of peripheral arterial occlusive diseases (author's transl)]. [German]. Schweizerische Rundschau fur Medizin Praxis1978;67(38):1407‐9. ">Hurlimann 1978</a>). </p> <p>See also <a href="./references#CD007371-sec-0091" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD007371-sec-0055"> <h3 class="title">Risk of bias in included studies</h3> <p>All five included trials were reported as randomised, controlled double‐blinded trials. Some trials did not report the method of randomisation (<a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a>) or blinding (<a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a>; <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a>). Only one trial presented a power calculation (<a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a>). Intention‐to‐treat analyses were not performed in the included trials with the exception of <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> in which all participants completed the study. </p> <p>Full details of each of the domains in the 'Risk of bias' tool are given below and summarised in <a href="#CD007371-fig-0002">Figure 2</a>, <a href="#CD007371-fig-0003">Figure 3</a>, and <a href="./references#CD007371-sec-0090" title="">Characteristics of included studies</a>. </p> <div class="figure" id="CD007371-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD007371-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD007371-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD007371-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> <section id="CD007371-sec-0056"> <h4 class="title">Allocation</h4> <p>For <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a>; <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a>; <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a>; <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a>, the allocation sequence was generated by random numbers, permutation list or automated computer lists. <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> did not report on allocation generation and concealment. </p> <p>For <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a>, in order to conceal the identity of the interventions from both the participants and investigation team, Padma 28 and placebo were identically packaged by the manufacturer, coded, and then handed over to the study teams. Although reported in less detail, <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a>; <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a>; and <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> appear to have used a similar process of concealment (stating the identical appearance of Padma 28 and placebo and that each had a code on its packaging). </p> </section> <section id="CD007371-sec-0057"> <h4 class="title">Blinding</h4> <p><a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> reported that the investigation team, outcome assessors, and participants in the study were blinded while conducting the study. Both Padma 28 and the placebo were identically packaged and coded. The drugs were produced by the manufacturer as capsules that were identical in appearance, taste, and packaging. The randomisation schedule was kept hidden until after the completion of data collection. <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> reported that participants and staff were blinded, with no additional details. While both <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> and <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> were reported to be double‐blinded trials, the authors did not provide further details of blinding. </p> </section> <section id="CD007371-sec-0058"> <h4 class="title">Incomplete outcome data</h4> <p>Please see <a href="#CD007371-tbl-0002">Table 1</a> for details. </p> <div class="table" id="CD007371-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Reasons for withdrawal</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4/40 withdrawals:</p> <p>3 insufficient time to participate</p> <p>1 non‐attendance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6/37 withdrawals:</p> <p>3 gastrointestinal discomfort</p> <p>1 poor compliance</p> <p>1 failure to improve</p> <p>1 death due to MI and CVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/50 withdrawals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/27 withdrawals:</p> <p>2 cardiac concerns</p> <p>1 toe amputation</p> <p>1 back pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/50 withdrawals:</p> <p>1 bladder carcinoma</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/35 withdrawals:</p> <p>1 gastrointestinal discomfort</p> <p>3 no improvement</p> <p>3 worsening conditions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/50 withdrawals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6/26 participants:</p> <p>2 cardiac concerns</p> <p>1 dyspnoea</p> <p>1 stroke</p> <p>1 lumbago</p> <p>1 other (no 'steady state' achieved after 4 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6/50 withdrawals:</p> <p>6 deterioration in overall condition</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CVA: cerebrovascular accident<br/> MI: myocardial infarction </p> </div> </div> <p>There were no withdrawals from <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a>. <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> reported that four participants, two in the treatment group and two in the placebo group, were excluded within the first month because of insufficient time to attend the study or due to non‐attendance. These exclusions were not related to clinical factors. <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a>; <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a>; and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> provided detailed explanations of the withdrawals from their studies. Numbers of withdrawals were equal between the treatments groups for <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> and <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> but a larger number of withdrawals was shown by <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> in the placebo group. Generally, the time points of withdrawals in <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a>; <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a>; and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> were described as before the end of the study period. </p> <p>In total, one patient in the Padma group (<a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a>) and four participants in the placebo groups (three from <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> and one from <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a>) withdrew because of no improvement in walking distance. An additional nine participants from the placebo groups (three from <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> and six from <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a>) withdrew because of a deterioration in walking distance. These withdrawals were directly related to the walking distance outcomes and make the <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> trials at high risk of attrition bias. </p> </section> <section id="CD007371-sec-0059"> <h4 class="title">Selective reporting</h4> <p><a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a>; <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a>; <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a>; and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> reported all of the intended outcomes. The main pre‐specified outcomes measured on the treadmill, PFWD and MWD, were reported for <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> but one additional outcome based on subjective evaluation of effectiveness by both the physician and the participants was not described. </p> </section> <section id="CD007371-sec-0060"> <h4 class="title">Other potential sources of bias</h4> <p>The <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> and <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> studies stated that the baseline characteristics of participants were not different between the Padma 28 and placebo groups. <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> reported that the distribution of patient characteristics was statistically random among the control groups at the time of randomisation. <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> listed some baseline characteristics but did not report on the differences of the baseline characteristics between the Padma 28 and placebo groups. <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> reported that the baseline characteristics of participants were not significantly different. However, confusing reports of the numbers and characteristics of evaluated participants were found. Of a total of 72 participants at baseline the numbers of withdrawals were 13, six from Padma 28 and seven from the placebo group. Thus the evaluated participants were 31 in the treatment group and 28 in the placebo group. ABI was tested on 25 participants, not 28, in the placebo group without any reason being given. Moreover, the measurement requiring exercise on the treadmill (not an outcome in this review) was completed in only 47 participants, 25 in the treatment group and 22 in the placebo group, without reasons being provided. </p> <p>The review authors are aware of one unpublished study (<a href="./references#CD007371-bbs2-0033" title="SommoggyS , SchleicherP . Therapy of PAOD with Padma 28. Study I ‐ Clinical and immunological effects of Padma 28 in patients with PAOD stage II according to Fontaine. Data reported in a systematic review by Melzer 2006.1990. [unpublished study] ">Sommoggy 1990</a>), as reported in a systematic review by <a href="./references#CD007371-bbs2-0025" title="MelzerJ , BrignoliR , DiehmC , ReichlingJ , DoDD , SallerR . Treating intermittent claudication with Tibetan medicine Padma 28: does it work?. Artherosclerosis2006;189(1):39‐46. ">Melzer 2006</a>. Contact with the pharmaceutical company and the authors of the systematic review proved unsuccessful in obtaining the required data. <a href="./references#CD007371-bbs2-0025" title="MelzerJ , BrignoliR , DiehmC , ReichlingJ , DoDD , SallerR . Treating intermittent claudication with Tibetan medicine Padma 28: does it work?. Artherosclerosis2006;189(1):39‐46. ">Melzer 2006</a> reported that this unpublished study provided the only data reported as not supporting a significant effect of Padma 28 compared with placebo. This can be seen as a form of publication bias. </p> </section> </section> <section id="CD007371-sec-0061"> <h3 class="title" id="CD007371-sec-0061">Effects of interventions</h3> <p>See: <a href="./full#CD007371-tbl-0001"><b>Summary of findings for the main comparison</b> Padma 28 versus placebo</a> </p> <p>All five included trials compared Padma 28 with a placebo. There was no comparison of Padma 28 with other medications. </p> <p>Change in walking distance (WD) (PFWD and MWD) was the preferred outcome for this review, especially in light of the differences in MWD between treatment groups at the start of the trials. However, limited data were presented on change in mean values, preventing a meta‐analysis of the difference in change between the two treatment groups. Therefore, descriptive details of the changes within each study group as well as the mean WD or median WD data after treatment are presented below and in the additional tables. </p> <p>Details of the available data for each of the included studies are presented by outcome below and in the additional tables. </p> <section id="CD007371-sec-0062"> <h4 class="title">Padma versus placebo</h4> <section id="CD007371-sec-0063"> <h5 class="title">Pain‐free walking distance (PFWD)</h5> <p>PFWD was reported in two studies (<a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a>; <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a>). Both studies reported PFWD in medians, with <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> reporting median baseline and follow‐up PFWD with interquartile ranges (IQRs) and <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> reporting change in median PFWD data as well as baseline and final value PFWD data. It should be noted that the two studies used different intensities of walking tests. See <a href="./references#CD007371-sec-0090" title="">Characteristics of included studies</a> for details. </p> <p>In <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> the median PFWD increased from 52 m (IQR 20 to 106) to 86 m (IQR 24 to 164) after four months of treatment in the Padma 28 group (P &lt; 0.01), and from 70 m (IQR 29 to 140) to 71 m (IQR 29 to 120) in the placebo group (P = not significant (NS)). The authors did not report on the change in median PFWD between the placebo and Padma 28 groups but changes in median PFWD were calculated by the review authors to be 34 m (Padma 28) versus 1 m (placebo). Converting median final PFWD values into mean PFWD values and calculating SDs allowed a comparison between the Padma 28 and placebo groups, showing a statistically non‐significant mean difference (MD) in PFWD of 15.00 m (95% CI ‐42.15 to 72.15, P = 0.61) (<a href="./references#CD007371-fig-0009" title="">Analysis 2.1</a>) </p> <p><a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> found that after 16 weeks of treatment, PFWD increased by 66 m in the Padma 28 group (P = 0.002) compared with 30 m in the placebo group (P = 0.01). This difference in change in PFWD between the treatment groups was not statistically significant (P = 0.06). While data on WD at the start and end of the trial were provided, no information on the variability was provided thereby making it not possible for the review authors to pool the final value PFWD data with the <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> study. In addition, due to the limited data the review authors deemed it inappropriate to impute SDs for changes in PFWD data and to pool the data. </p> <p>For additional details see <a href="#CD007371-tbl-0003">Table 2</a>. </p> <div class="table" id="CD007371-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Pain‐free walking distance</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Study</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Group</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Median baseline PFWD (m)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>IQR</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Median final PFWD (m)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>IQR</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Change in median PFWD (m)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>P*</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 ‐ 106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 ‐ 164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.01</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 ‐ 140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 ‐ 120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.002</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.01</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*P value refers to difference between baseline and follow‐up PFWD values<br/> IQR: interquartile range<br/> m: metres<br/> NS: not significant<br/> PFWD: pain‐free walking distance </p> </div> </div> </section> <section id="CD007371-sec-0064"> <h5 class="title">Maximum walking distance (MWD)</h5> <p>MWD was evaluated in four trials (<a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a>; <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a>; <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a>; <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a>). The final point of treatment was 16 weeks (four months) in all trials and the intensities of the walking tests were similar with the exception of <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a>, as described in <a href="#CD007371-sec-0049">Included studies</a>. </p> <p><a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> presented the outcome as a median but, as described in <a href="#CD007371-sec-0037">Measures of treatment effect</a>, on further investigation it was determined that their results were in fact mean values. <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> found a statistically significant change in MWD in the Padma 28 group with an improvement of 76 m (from 80.6 m to 156.2 m, P &lt; 0.001). The placebo group did not show a statistically significant change in mean MWD (68.1 m to 66.6 m, P &gt; 0.1). The authors did not report on the difference between the Padma 28 and placebo groups but this could be calculated from the available data, showing a statistically significant increase in MWD of 77.10 m (95% CI 53.41 to 100.79, P &lt; 0.00001, low quality evidence) (<a href="./references#CD007371-fig-0004" title="">Analysis 1.1</a>). In <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a>, the MWD was shown to have risen significantly by 100 m in the Padma 28 group (87.5 m to 187.7 m, P &lt; 0.001) and by 13 m in the placebo group (from 75.0 to 87.5 m, P = NS). <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> did not report the SDs for change in mean MWD. The authors did not report on the difference between the Padma 28 and placebo groups. Due to missing SDs for the mean MWD in <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a>, the change in MWD data could not be pooled with the <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> data. The review authors deemed it was inappropriate to impute the SDs with the limited number of studies included in this review. </p> <p>The MWD data after treatment from <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> were pooled showing a statistically significant difference in final MWD values between the Padma 28 and placebo groups (MD 95.97 m, 95% CI 79.07 to 112.88, P &lt; 0.00001, very low quality evidence) (<a href="./references#CD007371-fig-0005" title="">Analysis 1.2</a>). There was no evidence of heterogeneity (Chi<sup>2</sup> test P = 0.055). </p> <p><a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> and <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> used medians to report the outcome measure and the results were not pooled with <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a>. <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> detected a significant increase in median MWD of 112 m in the Padma 28 group (115 to 227 m, P &lt; 0.001) and an increase of 7 m in the placebo group (125 to 132 m, P = NS). This study also noted differences in effect size within the Padma 28 group with 7/18 participants at least doubling their MWD. Three participants in the Padma 28 group reached &gt; 500 m WD and were no longer restricted by IC in their daily life. In comparison, only one of 18 participants in the placebo group attained a doubling of WD distance and none of the placebo group achieved a WD of &gt; 500 m. The authors did not report the difference between the Padma 28 and placebo groups. <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> reported an increase in the median value of MWD by 124 m in the Padma 28 group (P &lt; 0.01) and 27 m (P = NS) in the placebo group. The authors reported that the increase in MWD was significantly different between the Padma 28 and placebo groups (P = 0.03). </p> <p>The median MWD data after treatment from <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> were deemed too skewed to pool with the final MWD data analysis of <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a>. Due to a lack of studies the review authors deemed the imputation of SDs for <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a>; <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a>; and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> inappropriate and therefore a sensitivity analysis of pooled change in MWD data with imputed data was not performed. </p> <p>For additional details see <a href="#CD007371-tbl-0004">Table 3</a>. </p> <div class="table" id="CD007371-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Maximum walking distance</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Study</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Group</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Mean baseline MWD (m)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>SD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Mean final MWD (m)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>SD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Change in mean MWD (m)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>SD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>P*</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>156.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 0.1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>187.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Study</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Group</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Median baseline MWD (m)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>IQR</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Median final MWD (m)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>IQR</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Change in median MWD (m)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>P</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 ‐ 218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73 ‐ &gt; 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59 ‐ 285</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64 ‐ 336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.01</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>168</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*P value refers to difference between baseline and follow up MWD values<br/> IQR: interquartile range<br/> m: metres<br/> MWD: maximum walking distance<br/> SD: standard deviation<br/> NS: not significant </p> </div> </div> </section> <section id="CD007371-sec-0065"> <h5 class="title">Adverse effects of therapy</h5> <p>In the four trials that reported data on side effects (<a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a>; <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a>; <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a>; <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a>), 24 out of 231 (10%) participants reported at least one adverse effect. Adverse effects from Padma 28 were found in two studies (<a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a>; <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a>), with <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> reporting that there were no adverse effects. The main adverse effects reported were gastrointestinal discomfort, tiredness, and skin eruptions. Pooling the adverse effects data showed there was no statistically significant difference in adverse effects between the Padma 28 and placebo groups (odds ratio (OR) 1.09, 95% CI 0.42 to 2.83, P = 0.86, very low quality evidence) (<a href="./references#CD007371-fig-0006" title="">Analysis 1.3</a>). There was no evidence of heterogeneity (Chi<sup>2</sup> test P = 0.44). <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> did not report numbers of adverse effects or numbers of participants affected by adverse effects. However, <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> did report that all side effects were mild in nature and that none required special treatment. In addition, <a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> reported that there was no significant difference between the treatment groups and that no participants stopped treatment because of adverse effects. </p> <p>See also <a href="#CD007371-tbl-0005">Table 4</a>. </p> <div class="table" id="CD007371-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Adverse effects</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 participants:</p> <p>3 gastrointestinal discomfort</p> <p>2 tiredness</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>8 in Padma 28 and 8 in placebo:</p> <p>stomach pain, gastrointestinal symptoms,</p> <p>and skin eruption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 participants:</p> <p>1 gastrointestinal discomfort</p> <p>2 tiredness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 reported</p> </td> </tr> </tbody> </table> </div> <p>Of the 34 withdrawals from the five studies, five where technical exclusions such as poor compliance (two) and insufficient time to participate (three); the remainder were patient withdrawals. There were 13/184 (7%) withdrawals from the Padma 28 groups and 21/181 (12%) withdrawals from the placebo groups. From the Padma 28 groups, 8/13 withdrawals were due to clinical concerns: two cardiac problems, three gastrointestinal discomfort, one back pain, one toe amputation, and one bladder carcinoma. In addition, the Padma 28 groups recorded a single death due to myocardial infarction in a participant with a complex cardiovascular history. From the placebo groups, 6/21 withdrawals were due to clinical concerns: two cardiac problems, one stroke, one lumbago, one dyspnoea (shortness of breath), and one gastrointestinal discomfort. In total, one patient in the Padma groups and four participants in the placebo groups withdrew because of no improvement in walking distance, and nine participants from the placebo groups withdrew because of a deterioration in walking distance. </p> <p>For additional details see <a href="#CD007371-tbl-0002">Table 1</a>. </p> </section> <section id="CD007371-sec-0066"> <h5 class="title">Ankle brachial index (ABI)</h5> <p>ABI was extracted from two studies (<a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a>; <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a>). </p> <p><a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> reported the median value of ABI after four months with a reduction of 0.03 in the Padma 28 group (0.62 to 0.59) and an increase of 0.02 in the placebo group (0.59 to 0.61), with no differences between baseline and follow‐up for the two groups. <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> did not compare the two groups with each other. </p> <p><a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> reported both final ABI values and the change in ABI values for both treatment groups. <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> reported no significant change in ABI after six months of treatment for both treatment groups. <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> did not analyse the difference between the Padma 28 and placebo groups but the data presented for the final ABI values indicated no significant difference between the two treatment groups for ABI values after treatment (MD ‐0.01, 95% CI ‐0.11 to 0.09, P = 0.84, very low quality evidence) (<a href="./references#CD007371-fig-0007" title="">Analysis 1.4</a>) and change in ABI values between baseline and at six months (MD ‐0.01, 95% CI ‐0.07 to 0.05, P = 0.72, very low quality evidence) (<a href="./references#CD007371-fig-0008" title="">Analysis 1.5</a>). </p> <p>A sensitivity analysis was performed in order to combine the ABI data of the <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> and <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> studies. The median ABI data after treatment from <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> were assumed to be the mean ABI data after treatment and SDs were calculated and pooled, showing no difference in ABI after treatment between the Padma 28 and placebo groups (MD ‐0.01, 95% CI ‐0.10 to 0.08, P = 0.79) (<a href="./references#CD007371-fig-0010" title="">Analysis 2.2</a>). Due to the lack of studies presenting change in ABI data, the review authors deemed it inappropriate to impute change in ABI data for the <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> study. </p> <p>For additional details see <a href="#CD007371-tbl-0006">Table 5</a>. </p> <div class="table" id="CD007371-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Ankle brachial index</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Study</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Group</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Mean baseline ABI</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>SD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Mean final ABI</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>SD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Change in mean ABI</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>SD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>P*</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Study</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Group</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Median baseline ABI</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>IQR</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Median final ABI</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>IQR</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Change in median ABI</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>P*</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42 ‐ 0.83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.43 ‐ 0.82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.39 ‐ 0.77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.39 ‐ 0.78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*P value refers to difference between baseline ABI and final ABI values<br/> ABI: ankle brachial index<br/> IQR: interquartile range<br/> NS: not significant<br/> SD: standard deviation </p> </div> </div> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007371-sec-0067" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007371-sec-0067"></div> <section id="CD007371-sec-0068"> <h3 class="title" id="CD007371-sec-0068">Summary of main results</h3> <p>Some evidence exists from individual trials to suggest that patients with intermittent claudication (IC) may benefit from daily Padma 28 in terms of moderate, short term (four month) improvements in walking distances (WDs). Neither Padma 28 nor placebo had any statistically significant effect on ankle brachial index (ABI). Side effects do not appear to be a problem. However, the longer term effects of treatment are unknown and the clinical significance of the improvements in WD are questionable. Moreover, the quality of the evidence is limited by the small sample size of the available trials, lack of detail on key elements required to assess other sources of bias for example around randomisation and blinding, limited reporting of statistical analyses that compared treatment groups, and relatively high withdrawal rates that were linked to outcome. That is, withdrawn if failed to improve walking distance. There was also some evidence of publication bias. </p> </section> <section id="CD007371-sec-0069"> <h3 class="title" id="CD007371-sec-0069">Overall completeness and applicability of evidence</h3> <p>All of the included trials were applicable to the general older population with IC. The participants of all studies were middle aged or older people (range 35 to 81 years) and were diagnosed by clinical examination or questionnaire and the WDs were tested on standardised equipment such as treadmills. </p> <p>The clinical significance of the change in WDs is questionable. Typically, the change in median PFWD reflected a doubling in median PFWD, ranging from 1 m to 66 m between the included studies. For change in mean or median MWD, the change in MWD ranged from ‐1.4 m to 124 m between the included studies. </p> </section> <section id="CD007371-sec-0070"> <h3 class="title" id="CD007371-sec-0070">Quality of the evidence</h3> <p>Overall, the included studies were of limited methodological quality. Two studies (<a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a>; <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a>) did not report details on participant or study personnel blinding, which could be considered a methodological limitation. <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> also did not report on all predefined outcomes for their study, which was therefore considered to be at high risk of selective reporting bias. </p> <p>Differences between the included studies in baseline participant characteristics such as smoking status of participants (e.g. baseline smoking rates 90% in <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> but 50% in <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> and <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a>) may have had an impact on the outcomes studied. </p> <p>The included trials were all small and the different reporting styles prevented pooling studies to produce a stronger result. In general, there was limited reporting of statistical analyses that compared the treatment groups. This resulted, in some cases, in the review authors using WDs after treatment rather than changes in WD. Since the baseline WDs varied between the studies the use of WDs after treatment could have introduced bias. </p> <p>There was a high rate of withdrawals linked to the outcome. That is they were withdrawn because of failing to improve WD or as a result of deterioration in overall condition (<a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a>; <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a>), introducing attrition bias. </p> <p>The quality of the evidence in this review is also limited by the review authors being unable to acquire additional information and data to allow more formal meta‐analyses of the primary or secondary outcomes. A meta‐analysis undertaken by <a href="./references#CD007371-bbs2-0025" title="MelzerJ , BrignoliR , DiehmC , ReichlingJ , DoDD , SallerR . Treating intermittent claudication with Tibetan medicine Padma 28: does it work?. Artherosclerosis2006;189(1):39‐46. ">Melzer 2006</a> included data from an unpublished study which we were unable to gain access to. This omission has the potential to alter the conclusions of the review (see <a href="#CD007371-sec-0072">Agreements and disagreements with other studies or reviews</a> below) and it may reflect previous negative publication bias. </p> <p>Overall the quality of the evidence according to the GRADE principles is very low, see <a href="./full#CD007371-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD007371-sec-0071"> <h3 class="title" id="CD007371-sec-0071">Potential biases in the review process</h3> <p>This review was conducted by following the review question and predefined protocol. Data analysis was undertaken using both narrative and statistical pooling methods in accordance with the available data. </p> <p>In some cases the review authors assumed that reported median WDs were mean WDs and calculated the corresponding SDs in order to pool the data with other studies. Such assumptions can introduce bias especially when very few studies are available. For this reason, these analyses were presented as sensitivity analyses. For this reason also, the review authors deemed it inappropriate to impute SDs of the change in WD data in order to pool the available change in WD data. </p> </section> <section id="CD007371-sec-0072"> <h3 class="title" id="CD007371-sec-0072">Agreements and disagreements with other studies or reviews</h3> <p>The meta‐analysis conducted by <a href="./references#CD007371-bbs2-0025" title="MelzerJ , BrignoliR , DiehmC , ReichlingJ , DoDD , SallerR . Treating intermittent claudication with Tibetan medicine Padma 28: does it work?. Artherosclerosis2006;189(1):39‐46. ">Melzer 2006</a> evaluated evidence on the efficacy and safety of Padma 28 in treating peripheral arterial occlusive disease, Fontaine stage II. The meta‐analysis was conducted according to a pre‐specified protocol, which the authors reported was guided by Cochrane methodology. Their analysis identified seven trials for investigating WD and then combined five of them. Five of the trials were the same studies as in this Cochrane review. However, <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> were excluded from the meta‐analysis by <a href="./references#CD007371-bbs2-0025" title="MelzerJ , BrignoliR , DiehmC , ReichlingJ , DoDD , SallerR . Treating intermittent claudication with Tibetan medicine Padma 28: does it work?. Artherosclerosis2006;189(1):39‐46. ">Melzer 2006</a> due to not having MWD data and because of concerns over differences in the baseline characteristics of the two treatment groups, respectively. The additional studies included by <a href="./references#CD007371-bbs2-0025" title="MelzerJ , BrignoliR , DiehmC , ReichlingJ , DoDD , SallerR . Treating intermittent claudication with Tibetan medicine Padma 28: does it work?. Artherosclerosis2006;189(1):39‐46. ">Melzer 2006</a> were an unpublished controlled trial (<a href="./references#CD007371-bbs2-0033" title="SommoggyS , SchleicherP . Therapy of PAOD with Padma 28. Study I ‐ Clinical and immunological effects of Padma 28 in patients with PAOD stage II according to Fontaine. Data reported in a systematic review by Melzer 2006.1990. [unpublished study] ">Sommoggy 1990</a>) and a historical re‐analysed non‐randomised study (<a href="./references#CD007371-bbs2-0031" title="SamochowiecL , WojcickiJ , KosmiderK , et al. Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. ">Samochowiec 1987b</a>). <a href="./references#CD007371-bbs2-0025" title="MelzerJ , BrignoliR , DiehmC , ReichlingJ , DoDD , SallerR . Treating intermittent claudication with Tibetan medicine Padma 28: does it work?. Artherosclerosis2006;189(1):39‐46. ">Melzer 2006</a> was able to access original data for nearly all of the studies, allowing a meta‐analysis to be undertaken. The results of <a href="./references#CD007371-bbs2-0033" title="SommoggyS , SchleicherP . Therapy of PAOD with Padma 28. Study I ‐ Clinical and immunological effects of Padma 28 in patients with PAOD stage II according to Fontaine. Data reported in a systematic review by Melzer 2006.1990. [unpublished study] ">Sommoggy 1990</a> were the only data reported as not supporting a significant effect of Padma 28 compared with placebo. Overall, the result of the meta‐analysis by <a href="./references#CD007371-bbs2-0025" title="MelzerJ , BrignoliR , DiehmC , ReichlingJ , DoDD , SallerR . Treating intermittent claudication with Tibetan medicine Padma 28: does it work?. Artherosclerosis2006;189(1):39‐46. ">Melzer 2006</a> was consistent with our own, with reporting of a significant difference in change in MWD between the two treatment groups (MWD 63.5 m, 95% CI 27.1 to 99.9 m, P &lt; 0.001). However, the clinical significance of this degree of improvement can be questioned. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007371-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/urn:x-wiley:14651858:media:CD007371:CD007371-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_t/tCD007371-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD007371-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full#CD007371-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007371-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/urn:x-wiley:14651858:media:CD007371:CD007371-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_t/tCD007371-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD007371-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full#CD007371-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007371-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/urn:x-wiley:14651858:media:CD007371:CD007371-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_t/tCD007371-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD007371-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full#CD007371-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007371-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/urn:x-wiley:14651858:media:CD007371:CD007371-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_t/tCD007371-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Padma 28 versus placebo, Outcome 1 Change in MWD." data-id="CD007371-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Padma 28 versus placebo, Outcome 1 Change in MWD.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/references#CD007371-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007371-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/urn:x-wiley:14651858:media:CD007371:CD007371-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_t/tCD007371-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Padma 28 versus placebo, Outcome 2 Final value MWD." data-id="CD007371-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Padma 28 versus placebo, Outcome 2 Final value MWD.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/references#CD007371-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007371-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/urn:x-wiley:14651858:media:CD007371:CD007371-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_t/tCD007371-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Padma 28 versus placebo, Outcome 3 Adverse effects." data-id="CD007371-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Padma 28 versus placebo, Outcome 3 Adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/references#CD007371-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007371-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/urn:x-wiley:14651858:media:CD007371:CD007371-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_t/tCD007371-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Padma 28 versus placebo, Outcome 4 Final value ankle brachial index." data-id="CD007371-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Padma 28 versus placebo, Outcome 4 Final value ankle brachial index.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/references#CD007371-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007371-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/urn:x-wiley:14651858:media:CD007371:CD007371-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_t/tCD007371-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Padma 28 versus placebo, Outcome 5 Change in ankle brachial index." data-id="CD007371-fig-0008" src="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Padma 28 versus placebo, Outcome 5 Change in ankle brachial index.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/references#CD007371-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007371-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/urn:x-wiley:14651858:media:CD007371:CD007371-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_t/tCD007371-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Padma 28 versus placebo sensitivity analysis, Outcome 1 Pain‐free walking distance." data-id="CD007371-fig-0009" src="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Padma 28 versus placebo sensitivity analysis, Outcome 1 Pain‐free walking distance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/references#CD007371-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007371-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/urn:x-wiley:14651858:media:CD007371:CD007371-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_t/tCD007371-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Padma 28 versus placebo sensitivity analysis, Outcome 2 Ankle brachial index." data-id="CD007371-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Padma 28 versus placebo sensitivity analysis, Outcome 2 Ankle brachial index. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/references#CD007371-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/media/CDSR/CD007371/image_n/nCD007371-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD007371-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Padma 28 versus placebo</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Should Padma 28 versus placebo be used for intermittent claudication?</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with symptomatic intermittent claudication<br/> <b>Setting:</b> outpatient setting<br/> <b>Intervention:</b> Padma 28<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Padma 28</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain free walking distance (PFWD)<br/> follow up: 4 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>see comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unable to pool data, one of the two studies did not provide variability data. Review authors deemed the limited available data inappropriate for imputation </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in maximum walking distance (MWD)<br/> follow up: 4 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in maximum walking distance was</p> <p> ‐ 1.4 metres</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in maximum walking distance in the Padma 28 group was 77.1 metres more (53.41 more to 100.79 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Final value MWD<br/> assessed with: treadmill<br/> follow up: 4 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean final value maximum walking distance was 77.05 metres</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean final value maximum walking distance in the Padma 28 group was 95.97 metres more (79.07 more to 112.88 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>193<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Adverse effects<br/> follow up: 4 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>OR 1.09<br/> (0.42 to 2.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>231<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 5 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>99 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>107 per 1000<br/> (44 to 237) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>52 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>56 per 1000<br/> (22 to 134) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Final value ankle brachial index (ABI)<br/> follow up: 4 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean final value ankle brachial index was 0.73</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean final value ankle brachial index in the Padma 28 group was 0.01 fewer (0.11 fewer to 0.09 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in ABI<br/> follow up: 4 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in ankle brachial index was ‐ 0.01</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in ankle brachial index in the Padma 28 group was 0.01 fewer (0.07 fewer to 0.05 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>ABI:</b> Ankle brachial index; <b>CI:</b> Confidence interval; <b>MWD:</b> Maximum walking distance; <b>RCT:</b> Randomised controlled trial <b>OR:</b> Odds ratio; <b>WD:</b> Walking distance </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> possible publication bias as data of one study unavailable ‐ downgraded by one level<br/> <sup>2</sup> one single study, unable to asses inconsistency ‐ downgraded by one level<br/> <sup>3</sup> high withdrawal rate linked to the outcome that is they were withdrawn because of failing to improve WD or as a result of deterioration in overall condition in <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> ‐ downgraded by one level<br/> <sup>4</sup> limited reporting of statistical analyses that compared the PADMA 28 and placebo groups: WD after treatment used rather than change in WD. Since the baseline WDs varied between the studies the use of WDs after treatment could have introduced bias ‐ downgraded by one level<br/> <sup>5</sup> differences between studies in baseline characteristics such as smoking: e.g. baseline smoking rates 90% in <a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> but 50% in <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> and <a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> ‐ downgraded by one level<br/> <sup>6</sup> high withdrawal rate linked to the outcome that is they were withdrawn because of failing to improve WD or as a result of deterioration in overall condition in <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> and <a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> ‐ downgraded by one level<br/> <sup>7</sup> high withdrawal rate linked to the outcome that is they were withdrawn because of failing to improve WD or as a result of deterioration in overall condition in <a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> ‐ downgraded by one level </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Padma 28 versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full#CD007371-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007371-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Reasons for withdrawal</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4/40 withdrawals:</p> <p>3 insufficient time to participate</p> <p>1 non‐attendance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6/37 withdrawals:</p> <p>3 gastrointestinal discomfort</p> <p>1 poor compliance</p> <p>1 failure to improve</p> <p>1 death due to MI and CVA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/50 withdrawals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/27 withdrawals:</p> <p>2 cardiac concerns</p> <p>1 toe amputation</p> <p>1 back pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/50 withdrawals:</p> <p>1 bladder carcinoma</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/35 withdrawals:</p> <p>1 gastrointestinal discomfort</p> <p>3 no improvement</p> <p>3 worsening conditions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/50 withdrawals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6/26 participants:</p> <p>2 cardiac concerns</p> <p>1 dyspnoea</p> <p>1 stroke</p> <p>1 lumbago</p> <p>1 other (no 'steady state' achieved after 4 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6/50 withdrawals:</p> <p>6 deterioration in overall condition</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>CVA: cerebrovascular accident<br/> MI: myocardial infarction </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Reasons for withdrawal</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full#CD007371-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007371-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Pain‐free walking distance</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Study</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Group</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Median baseline PFWD (m)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>IQR</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Median final PFWD (m)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>IQR</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Change in median PFWD (m)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>P*</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 ‐ 106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 ‐ 164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.01</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 ‐ 140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 ‐ 120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.002</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.01</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>*P value refers to difference between baseline and follow‐up PFWD values<br/> IQR: interquartile range<br/> m: metres<br/> NS: not significant<br/> PFWD: pain‐free walking distance </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Pain‐free walking distance</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full#CD007371-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007371-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Maximum walking distance</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Study</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Group</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Mean baseline MWD (m)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>SD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Mean final MWD (m)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>SD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Change in mean MWD (m)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>SD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>P*</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007371-bbs2-0003" title="SamochowiecL , WojcickiJ , KosmiderJ , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances [Wirksamkeitsprüfung von PADMA 28 bei der Behandlung von Patienten mit chronischen arteriellen Durchblutungsstörungen]. Herba Polonica1987;33:29‐41. SamochowiecL , WojcickiJ , KosmiderK , DadejR , SmulskiH . Potency test of Padma 28 in the treatment of patients with chronic arterial circulatory disturbances (intermittent claudication, Fontaine stage II). Polbiopharm Reports1987;22:3‐14. SamochowiecL , WojcickiJ , KosmiderK , SmulskiHS . The effectiveness of PADMA‐28 on intermittent claudication. Therapie1988; Vol. 43:155. ">Samochowiec 1987</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>156.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 0.1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>187.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Study</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Group</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Median baseline MWD (m)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>IQR</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Median final MWD (m)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>IQR</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Change in median MWD (m)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>P</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 ‐ 218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73 ‐ &gt; 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59 ‐ 285</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64 ‐ 336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.01</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>168</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>*P value refers to difference between baseline and follow up MWD values<br/> IQR: interquartile range<br/> m: metres<br/> MWD: maximum walking distance<br/> SD: standard deviation<br/> NS: not significant </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Maximum walking distance</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full#CD007371-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007371-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Adverse effects</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007371-bbs2-0004" title="SchraderR , NachburB , MahlerF . Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication. Schweizerische Medizinische Wochenschrift1985;115(22):752‐6. ">Schräder 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007371-bbs2-0005" title="SmulskiHS . Treatment of chronic ischemia of the lower extremities with a complex herbaceous preparation. Annales Academiae Medicae Stetinensis1991;37:191‐202. SmulskiHS , WojcickiJ . Placebo‐controlled, double‐blind trial to determine the efficacy of the Tibetan plant preparation Padma 28 for intermittent claudication. Alternative Therapies in Health and Medicine1995;1(3):44‐9. SmulskiHS , WójcickiJ . Placebo‐controlled double‐blind study on the effect of Tibetan herbal preparation Padma 28 on claudication intermittens. Forschende Komplementärmedizin1994;1:18‐26. ">Smulski 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 participants:</p> <p>3 gastrointestinal discomfort</p> <p>2 tiredness</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>8 in Padma 28 and 8 in placebo:</p> <p>stomach pain, gastrointestinal symptoms,</p> <p>and skin eruption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 participants:</p> <p>1 gastrointestinal discomfort</p> <p>2 tiredness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 reported</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Adverse effects</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full#CD007371-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007371-tbl-0006"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Ankle brachial index</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Study</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Group</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Mean baseline ABI</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>SD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Mean final ABI</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>SD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Change in mean ABI</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>SD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>P*</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007371-bbs2-0002" title="SallonS , BeerG , RosenfeldJ , AnnerH , VolcoffD , GinsbergG , et al. The efficacy of Padma 28, a herbal preparation, in the treatment of intermittent claudication: a controlled double‐blind pilot study with objective assessment of chronic occlusive arterial disease patients. Journal of Vascular Investigation1998;4(3):129‐36. ">Sallon 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Study</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Group</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Median baseline ABI</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>IQR</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Median final ABI</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>IQR</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Change in median ABI</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>P*</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007371-bbs2-0001" title="DrabaekH , MehlsenJ , HimmelstrupH , WintherK . A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology1993;44(11):863‐7. DrabaekH , MehlsenJ , PetersenJR , HimmelstrupH , HansenKF . Padma‐28, a herbal preparation, increases walking distance in patients with intermittent claudication. Ugeskrift for Laeger1994;156(42):6207‐9. MehlsenJ , DrabaekH , PetersenJR , WintherK . The effect of Tibetan herbal mixture (Padma 28) on walking distance in stable intermittent claudication. Forschende Komplementärmedizin1995;2:240‐5. WintherK , KharazmiA , HimmelstrupH , DrabaekH , MehlsenJ . PADMA‐28, A botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication. Fibrinolysis1994;8 Suppl 2:47‐9. ">Mehlsen 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Padma 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42 ‐ 0.83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.43 ‐ 0.82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.39 ‐ 0.77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.39 ‐ 0.78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>*P value refers to difference between baseline ABI and final ABI values<br/> ABI: ankle brachial index<br/> IQR: interquartile range<br/> NS: not significant<br/> SD: standard deviation </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Ankle brachial index</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/full#CD007371-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007371-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Padma 28 versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in MWD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Final value MWD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>95.97 [79.07, 112.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.42, 2.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Final value ankle brachial index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Change in ankle brachial index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Padma 28 versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/references#CD007371-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007371-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Padma 28 versus placebo sensitivity analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain‐free walking distance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Imputed final value data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Ankle brachial index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.10, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Final value data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.11, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Imputed final value data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.21, 0.17]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Padma 28 versus placebo sensitivity analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007371.pub3/references#CD007371-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007371.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD007371-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD007371-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007371-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD007371-note-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD007371-note-0003">日本語</a> </li> <li class="section-language"> <a class="" href="ru#CD007371-note-0002">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007371\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007371\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007371\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007371\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007371\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007371\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007371\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007371\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007371\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007371\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007371\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007371\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007371\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007371\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007371\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007371\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007371\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007371\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=na56WA6j&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007371.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007371.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007371.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007371.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007371.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724230735"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007371.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724230738"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007371.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e5dc1dfeef409',t:'MTc0MDcyNDIzMS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 